← Open Payments lookup

CRYSTAL DYER: Open Payments

NPI 1053861609 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,238 in 76 payments from 19 companies in 2025. Trend: 2023 $993 · 2024 $958 · 2025 $1,238

Food & beverage: $1,238
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$227
ABBVIE INC.14$147
Teva Pharmaceuticals USA, Inc.10$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$135
Otsuka America Pharmaceutical, Inc.4$82
Lilly USA, LLC3$57
Phathom Pharmaceuticals, Inc.4$56
Boehringer Ingelheim Pharmaceuticals, Inc.3$48
Novo Nordisk Inc3$45
Vanda Pharmaceuticals Inc.2$42

Products named: CAPLYTA, BREZTRI, VRAYLAR, REXULTI, UZEDY, FARXIGA, JARDIANCE, VOQUEZNA.

Industry payments across MO — which companies pay providers there.